SE8401190L - benzamide - Google Patents

benzamide

Info

Publication number
SE8401190L
SE8401190L SE8401190A SE8401190A SE8401190L SE 8401190 L SE8401190 L SE 8401190L SE 8401190 A SE8401190 A SE 8401190A SE 8401190 A SE8401190 A SE 8401190A SE 8401190 L SE8401190 L SE 8401190L
Authority
SE
Sweden
Prior art keywords
sulphamoyl
lower alkyl
hydrogen
signifies
dichloro
Prior art date
Application number
SE8401190A
Other languages
Swedish (sv)
Other versions
SE8401190D0 (en
SE466447B (en
Inventor
Prada M Da
R Joos
E Kyburz
P C Wyss
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of SE8401190D0 publication Critical patent/SE8401190D0/en
Publication of SE8401190L publication Critical patent/SE8401190L/en
Publication of SE466447B publication Critical patent/SE466447B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/77—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Abstract

Benzamides of the formula <IMAGE> wherein R<1> and R<2> each independently signify hydrogen, halogen, lower alkyl, lower alkoxy, cyano, trifluoromethyl, sulphamoyl, mono(lower alkyl)sulphamoyl or di(lower alkyl)sulphamoyl or R<1> and R<2> on adjacent carbon atoms together signify a methylenedioxy group, with the proviso that R<2> is different from hydrogen when R<1> signifies bromine in the 3-position, and their pharmaceutically usable acid addition salts have interesting monoamine oxidase inhibiting properties with low toxicity and can accordingly be used for the treatment of depressive states and Parkinsonism. Those compounds of formula I in which R<1> signifies halogen, cyano or trifluoromethyl in the para-position and R<2> signifies hydrogen or R<1> and R<2> together signify 2,4-dichloro, 3,4-dichloro or 3,4-methylenedioxy are novel; these novel compounds can be manufactured according to methods known per se.
SE8401190A 1983-03-03 1984-03-02 N-AMINOETHYL BENZAMIDE DERIVATIVES AND PHARMACEUTICAL PREPARATIONS THEREOF SE466447B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1150/83A CH653670A5 (en) 1983-03-03 1983-03-03 BENZAMIDE DERIVATIVES.

Publications (3)

Publication Number Publication Date
SE8401190D0 SE8401190D0 (en) 1984-03-02
SE8401190L true SE8401190L (en) 1984-09-04
SE466447B SE466447B (en) 1992-02-17

Family

ID=4203649

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8401190A SE466447B (en) 1983-03-03 1984-03-02 N-AMINOETHYL BENZAMIDE DERIVATIVES AND PHARMACEUTICAL PREPARATIONS THEREOF

Country Status (28)

Country Link
JP (1) JPS59167552A (en)
KR (1) KR910008202B1 (en)
AR (1) AR243155A1 (en)
AT (1) AT390948B (en)
AU (2) AU570431B2 (en)
BE (1) BE899059A (en)
CA (1) CA1252794A (en)
CH (1) CH653670A5 (en)
DE (1) DE3407654C2 (en)
DK (1) DK166382C (en)
ES (3) ES8504680A1 (en)
FI (1) FI79297C (en)
FR (1) FR2541996B1 (en)
GB (1) GB2135998B (en)
GR (1) GR81866B (en)
HU (1) HU193556B (en)
IE (1) IE57004B1 (en)
IL (1) IL71078A (en)
IT (1) IT1173365B (en)
LU (1) LU85231A1 (en)
MC (1) MC1568A1 (en)
NL (1) NL8400459A (en)
NO (1) NO165999C (en)
NZ (1) NZ207272A (en)
PH (1) PH19623A (en)
PT (1) PT78187B (en)
SE (1) SE466447B (en)
ZA (1) ZA841394B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1261335A (en) * 1984-08-29 1989-09-26 Hoffmann-La Roche Limited/Hoffmann-La Roche Limitee Ethylenediamine monoamide derivatives
US4772630A (en) * 1984-11-23 1988-09-20 Ciba-Geigy Corp. Benzamides and their salts
NZ219974A (en) * 1986-04-22 1989-08-29 Goedecke Ag N-(2'-aminophenyl)-benzamide derivatives, process for their preparation and their use in the control of neoplastic diseases
FR2642972B1 (en) * 1989-02-14 1994-08-05 Inst Nat Sante Rech Med AGENTS FOR THE DIAGNOSIS AND TREATMENT OF MELANOMAS, HALOGENATED AROMATIC DERIVATIVES SUITABLE FOR USE AS SUCH AGENTS AND THEIR PREPARATION
WO2014155184A1 (en) * 2013-03-28 2014-10-02 Rhenovia Pharma Treatment for parkinson's disease

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3342679A (en) * 1967-09-19 Parts by weight of acid chloride to react with parts of amine in
FR6557M (en) * 1967-06-20 1968-12-23 Ile De France
GB1455116A (en) * 1972-12-15 1976-11-10 Ici Ltd Pharmaceutical compositions
GB1520584A (en) * 1975-04-02 1978-08-09 Yamanouchi Pharma Co Ltd 2 - alkoxy - 5 substituted benzamide derivatives and their use in pharmaceutical compositions
DE2616486A1 (en) * 1976-04-14 1977-11-03 Basf Ag Perylene tetracarboxylic acid diimide pigments - for use in paints, thermoplastics, etc. and as vat dyes
CA1206964A (en) * 1980-11-12 1986-07-02 Nobuo Shinma Tetra-substituted benzene derivatives
DE3200258A1 (en) * 1982-01-07 1983-07-21 Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München SUBSTITUTED 1-BENZOYL-2-PHENYLIMINO IMIDAZOLIDINE, THE ACID ADDITION SALTS THEREOF, METHOD FOR THE PRODUCTION THEREOF AND THE MEDICINAL PRODUCTS CONTAINING THE SAME
IL69997A0 (en) * 1983-01-03 1984-01-31 Miles Lab Procainamide and n-acetylprocainamide immunogens,antibodies prepared therefrom,labeled conjugates,and the use of such antibodies and labeled conjugates in immunoassays
US4808624A (en) * 1984-06-28 1989-02-28 Bristol-Myers Company Pharmacologically active substituted benzamides

Also Published As

Publication number Publication date
MC1568A1 (en) 1985-02-04
JPH0430389B2 (en) 1992-05-21
IL71078A0 (en) 1984-05-31
PT78187A (en) 1984-04-01
NO840797L (en) 1984-09-04
PH19623A (en) 1986-06-04
AU570431B2 (en) 1988-03-17
GB2135998A (en) 1984-09-12
NO165999C (en) 1991-05-15
ES8506600A1 (en) 1985-08-16
ES537045A0 (en) 1985-08-16
AR243155A1 (en) 1993-07-30
FI79297B (en) 1989-08-31
ES530230A0 (en) 1985-05-01
IT1173365B (en) 1987-06-24
FR2541996A1 (en) 1984-09-07
FI840734A (en) 1984-09-04
AU2506684A (en) 1984-09-06
ES537046A0 (en) 1985-08-16
AU609758B2 (en) 1991-05-09
CH653670A5 (en) 1986-01-15
BE899059A (en) 1984-09-03
JPS59167552A (en) 1984-09-21
IE57004B1 (en) 1992-03-11
GB8405486D0 (en) 1984-04-04
NL8400459A (en) 1984-10-01
FR2541996B1 (en) 1987-12-11
DE3407654A1 (en) 1984-09-06
AU8307987A (en) 1988-06-16
ATA72484A (en) 1990-01-15
DE3407654C2 (en) 1994-04-07
AT390948B (en) 1990-07-25
NO165999B (en) 1991-02-04
ES8506601A1 (en) 1985-08-16
LU85231A1 (en) 1985-09-12
CA1252794A (en) 1989-04-18
ZA841394B (en) 1985-06-26
DK147584D0 (en) 1984-02-29
FI79297C (en) 1989-12-11
DK166382B (en) 1993-05-10
NZ207272A (en) 1987-07-31
KR910008202B1 (en) 1991-10-11
DK166382C (en) 1993-09-27
SE8401190D0 (en) 1984-03-02
IL71078A (en) 1987-12-31
SE466447B (en) 1992-02-17
DK147584A (en) 1984-09-04
IT8419778A0 (en) 1984-02-23
ES8504680A1 (en) 1985-05-01
FI840734A0 (en) 1984-02-22
IE840512L (en) 1984-09-03
HU193556B (en) 1987-10-28
PT78187B (en) 1986-08-05
GB2135998B (en) 1986-09-24
GR81866B (en) 1984-12-12
KR840009077A (en) 1984-12-24

Similar Documents

Publication Publication Date Title
PT81603B (en) PROCESS FOR THE PREPARATION OF MEVALONOLACTOMA INDIAN ANALOGS AND / OR ITS DERIVATIVES
JP2003511415A5 (en)
ES8301980A1 (en) 8-Arylalkyl-3-phenyl-3-nortropanols, their acid addition salts, pharmaceutical compositions containing them and processes for their preparation.
IT1171879B (en) DERIVATIVES OF 2-AMINO-3-ACYLAMIN-6-BENZYLAMINE-PYRIDIN HAVING ANTIEPILEEPTIC ACTION
SE8504014D0 (en) AETHYLENDIAMINMONOAMID-Derivate
SE8401190L (en) benzamide
SE7500954L (en)
ES543368A0 (en) PROCEDURE FOR THE OBTAINING OF DERIVATIVES OF 1-FLUORO-1- -AZOLIL-2,2-DIARIL-ETANO
ES515106A0 (en) &#34;PROCEDURE FOR THE PREPARATION OF 1-PHENYLINDAZOLE-3-ONA COMPOUNDS&#34;.
ES533320A0 (en) PROCEDURE FOR PREPARING 1-ACETONYL-2- (PHENYLIMINE) -IMIDAZOLIDINES
ES464483A1 (en) Anti-inflammatory 2-sulphonyl- (or -sulphinyl)-2&#39;-aminoacetophenones
ES8609207A1 (en) Phenylethylamine derivatives
ES8307253A1 (en) Dioxazabicyclic derivatives
DE3464602D1 (en) 4-alkylimidazole derivatives, their preparation and their application
FI955680A (en) Psoralen derivatives, their preparation and use
ES544670A0 (en) PROCEDURE FOR PREPARING NEW 11-PIPERAZINYL-5H-IMIDAZO (2,1-C) (1,4) -BENZODIAZEPINES
IE802690L (en) Substituted 2-phenylamino-imidazolines-(2)
ATE17710T1 (en) KETEN-0,0-ACETALS AND PROCESS FOR THEIR PRODUCTION.
ES8200663A1 (en) N-(4-pyridylmethyl)benzamides and Their Production
ES433957A1 (en) Novel phenothiazines
ES557788A0 (en) PROCEDURE FOR PREPARING AN ANTHRACICLINONE
ES532179A0 (en) PROCEDURE FOR PREPARING NEW SEMICARBAZIDS

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8401190-7

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8401190-7

Format of ref document f/p: F